Earnings tumbled – Axiata’s reported 2Q20 PATAMI plunged 58% YoY to RM80m while underlying PATAMI dropped 81% YoY to RM44m due to higher depreciation & amortisation, lower revenue due to Covid-19 and higher losses from digital business due to e-Tunai Rakyat contribution. Amid Covid-19, management estimates revenue loss of RM400m and has handed out RM80m in CSR assistance.
Decline revenue - Quarterly revenue dropped 6% YoY to RM5.67b due to lower contribution from all operating companies (OpCos) except XL, Robi and Smart.
Challenging year - For the first six months, 1H20 reported PATAMI dropped 72% YoY to RM268m while underlying PATAMI declined 62% YoY to RM166m due to one-off items namely Celcom employee restructuring cost (RM77m) and XL’s gain from tower sale (RM299m), as well as forex loss (RM103m). Meanwhile, 1H20 revenue was 2.3% YoY lower at RM11.83b.
Stable gearing – Net debt/EBITDA inched up to 2.06x vs 2.05x in 1Q20.
Earnings Outlook/Revision
Earnings below expectation – 1H20 revenue and EBITDA came within forecasts but PATAMI of RM166m only achieved 23% of our full year forecast.
Forecast slashed – We are reducing our FY20 EPS forecast by 31% following the higher-than-expected loss in digital business as well as higher tax rate.
Dividend – Axiata declared an interim dividend of 2 sen/share.
COVID-19 update – In 2Q20, Axiata felt the full impact of Covid-19 in April but has since started to recover with revenue growth climbing back to pre-lockdown levels.
Valuation & Recommendation
Maintain BUY with a lower target price of RM3.93 (previously RM4.15) based on Sum-Of-Parts (SOP). We expect earnings growth to accelerate in 2H20 with lockdowns being lifted and economies restarting.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....